Martin Ashdown is a Melbourne based scientist, Research Fellow at the Faculty of Medicine University of Melbourne. Martin has made the observation that the immune response in the late stage cancer patient is oscillating repeatedly over an approximate seven day period or cycle. This observation may have profound implications for the timed delivery of various therapies, which via immune modulation may increase complete response rates, reduce toxicity and substantially reduce the cost of treatment. Martin has co-designed trials at international institutions and presented at international conferences advocating monitoring patients prior to treatment and accurately timing therapy as pulses.This technique, known as “Immune Synchronization” is believed to already happen accidentally is those patients who successfully respond to therapy with a complete response. Martin and colleagues suggest that the drugs and resources to successfully treat cancer are already here, but need to be used more accurately.